EVINACUMAB-DGNB for Hypercholesterolaemia: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 8 adverse event reports in the FDA FAERS database where EVINACUMAB-DGNB was used for Hypercholesterolaemia.
Most Reported Side Effects for EVINACUMAB-DGNB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 14 | 15.2% | 0 | 1 |
| Fatigue | 12 | 13.0% | 0 | 2 |
| Pain | 9 | 9.8% | 0 | 1 |
| Hepatic steatosis | 7 | 7.6% | 0 | 0 |
| Diarrhoea | 6 | 6.5% | 0 | 0 |
| Dizziness | 6 | 6.5% | 0 | 0 |
| Drug ineffective | 6 | 6.5% | 0 | 1 |
| International normalised ratio increased | 6 | 6.5% | 0 | 0 |
| Product dose omission issue | 6 | 6.5% | 0 | 0 |
| Death | 5 | 5.4% | 5 | 0 |
| Headache | 5 | 5.4% | 0 | 0 |
Other Indications for EVINACUMAB-DGNB
Other Drugs Used for Hypercholesterolaemia
EVOLOCUMAB (23,505)
ATORVASTATIN (5,615)
ALIROCUMAB (4,924)
SIMVASTATIN (3,010)
ROSUVASTATIN (2,690)
EZETIMIBE (1,589)
PRAVASTATIN (764)
INCLISIRAN (486)
FENOFIBRATE (286)
FLUVASTATIN (264)